0001752724-20-205284.txt : 20201013 0001752724-20-205284.hdr.sgml : 20201013 20201013090332 ACCESSION NUMBER: 0001752724-20-205284 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200731 FILED AS OF DATE: 20201013 DATE AS OF CHANGE: 20201013 EFFECTIVENESS DATE: 20201013 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AB PORTFOLIOS CENTRAL INDEX KEY: 0000812015 IRS NUMBER: 000000000 FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-05088 FILM NUMBER: 201234855 BUSINESS ADDRESS: STREET 1: ALLIANCEBERNSTEIN LP STREET 2: 1345 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10105 BUSINESS PHONE: 2129691000 MAIL ADDRESS: STREET 1: ALLIANCEBERNSTEIN LP STREET 2: 1345 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10105 FORMER COMPANY: FORMER CONFORMED NAME: ALLIANCEBERNSTEIN PORTFOLIOS DATE OF NAME CHANGE: 20030319 FORMER COMPANY: FORMER CONFORMED NAME: ALLIANCE PORTFOLIOS DATE OF NAME CHANGE: 19930812 FORMER COMPANY: FORMER CONFORMED NAME: EQUITABLE FUNDS DATE OF NAME CHANGE: 19920703 0000812015 S000010509 AB Growth Fund C000028997 Class A AGRFX C000028998 Class B AGBBX C000028999 Class C AGRCX C000029000 Advisor Class AGRYX C000029001 Class R AGFRX C000029002 Class K AGFKX C000029003 Class I AGFIX N-CEN 1 primary_doc.xml X0303 N-CEN LIVE 0000812015 XXXXXXXX 811-05088 false false false N-1A S000010509 C000028999 C000029002 C000028997 C000029001 C000028998 C000029003 C000029000 AB PORTFOLIOS 811-05088 0000812015 549300SL79FN46SWRF45 ALLIANCEBERNSTEIN LP 1345 AVENUE OF THE AMERICAS NEW YORK 10105 US-NY US 212-969-1000 State Street Bank and Trust Company 1 Lincoln Street Boston 02111 617-786-3000 Custody and Accounting Records N N N-1A 6 Y Michael J. Downey 000000000 N Garry L. Moody 000000000 N Earl D. Weiner 000000000 N Jeanette Loeb 000000000 N Nancy P. Jacklin 000000000 N Carol C. McMullen 000000000 N Jorge A. Bermudez 000000000 N Marshall C. Turner, Jr. 000000000 N Robert M. Keith 002309907 Y Vincent S. Noto 000000000 1345 Avenue of the Americas New York 10105 XXXXXX N N N N N N AllianceBernstein Investments, Inc. 8-30851 000014549 0000000000 Y N Ernst & Young LLP 42 00000000000000000000 N N N N N N N AB Growth Fund S000010509 549300UM1VFAB7ZJOJ94 N 8 0 0 N/A N N Y N N State Street Bank and Trust Company 571474TGEMMWANRLN572 N N Revenue sharing split 89743111.14000000 123847.00000000 Rule 32a-4 (17 CFR 270.32a-4) Rule 12d1-1 (17 CFR 270.12d1-1) Rule 22d-1 (17 CFR 270.22d-1) Y Y N N AllianceBernstein L.P. 801-56720 000108477 0JK55UGWSWNF3X7KLQ85 N AllianceBernstein Investor Services, Inc. 084-01187 0000000000 Y N N Refinitiv US Holdings Inc. 549300NF240HXJO7N016 N Vertical Management Systems, Inc. 27-3275288 Tax ID N ICE Data Services, Inc. 13-3668779 Tax ID N Standard & Poor's Financial Services LLC 549300U4VWNITEKO2881 N PricingDirect Inc. 549300WIC0TOJ7N7GD54 N Bloomberg L.P. 549300B56MD0ZC402L06 N IHS Markit Ltd. 549300HLPTRASHS0E726 GB N N Deutsche Bank Societa per Azioni 529900SS7ZWCX82U3W60 IT N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) Mizuho Bank, Ltd. (Minato ku, Tokyo, JP, Branch) RB0PEZSDGCO3JS6CEU02 JP N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) State Street Bank and Trust Company (Edinburgh, GB, Branch) 571474TGEMMWANRLN572 GB N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) State Street Bank and Trust Company 571474TGEMMWANRLN572 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) Deutsche Bank Aktiengesellschaft (Amsterdam, Noord Holland, NL, Branch) 7LTWFZYICNSX8D621K86 NL N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) Clearstream Banking S.A. 549300OL514RA0SXJJ44 LU N Y Foreign securities depository - rule 17f-7 (17 CFR 270.17f-7) UBS Switzerland AG 549300WOIFUSNYH0FL22 CH N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) N AllianceBernstein Investor Services, Inc. 0000000000 Y N N AllianceBernstein L.P. 0JK55UGWSWNF3X7KLQ85 Y N N Sanford C. Bernstein Limited N/A 000000000 54930049G8WQ5OOUSD19 GB 0.00000000 Sanford C. Bernstein & Co., LLC 8-52942 000104474 549300I7JYZHT7D5CO04 0.00000000 Morgan Stanley & Co. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 9734.96000000 Cowen and Company, LLC 8-22522 000007616 549300WR155U7DVMIW58 17972.07000000 Citation Group Ltd. 8-43632 000028305 00000000000000000000 8371.68000000 Credit Suisse Securities (USA) LLC 8-422 000000816 1V8Y6QCX6YMJ2OELII46 11981.85000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 8557.13000000 Virtu Itg LLC 8-44218 000029299 549300S41SMIODVIT266 3351.03000000 UBS Securities LLC 8-22651 000007654 T6FIZBDPKLYJKFCRVK44 8738.63000000 Citigroup Global Markets Inc. 8-8177 000007059 MBNUM2BPBDO7JBLYG310 9286.74000000 Barclays Capital Inc. 8-41342 000019714 AC28XWWI3WIBK2824319 8958.29000000 Goldman Sachs & Co. LLC 8-129 000000361 FOR8UP27PHTHYVLBNG30 18767.34000000 116505.78000000 State Street Bank and Trust Company N/A 000000000 571474TGEMMWANRLN572 619020534.93000000 619020534.93000000 Y 1192747255.58000000 Committed 325000000.00000000 N N N N true INTERNAL CONTROL RPT 2 NCEN_2196581506781068.txt Report of Independent Registered Public Accounting Firm To the Shareholders and Board of Trustees of AB Growth Fund: In planning and performing our audit of the financial statements of AB Growth Fund, (the "Fund"), (one of the series constituting The AB Portfolios, as of and for the year ended July 31, 2020, in accordance with the standards of the Public Company Accounting Oversight Board (United States), we considered the Fund's internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we express no such opinion. The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and trustees of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company's assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Fund's internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the Public Company Accounting Oversight Board (United States). However, we noted no deficiencies in the Fund's internal control over financial reporting and its operation, including controls over safeguarding securities that we consider to be a material weakness as defined above as of July 31, 2020. This report is intended solely for the information and use of management and the Board of Trustees of AB Growth Fund and the Securities and Exchange Commission, and is not intended to be and should not be used by anyone other than these specified parties. /s/ ERNST & YOUNG LLP New York, New York September 25, 2020